Cargando…

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES

Detalles Bibliográficos
Autores principales:	Arif, Yousif, Stefanko, Alexa, Garcia, Nicholas Jason, Beshai, David, Fan, Wenjun, Wong, Nathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972788/ http://dx.doi.org/10.1016/S0735-1097(22)02839-X

Ejemplares similares

Estimated Atherosclerotic Cardiovascular Disease Risk: Disparities and Severe COVID-19 Outcomes (from the National COVID Cohort Collaborative)
por: Arif, Yousif A., et al.
Publicado: (2022)

ACCURACY OF THE GRACE SCORE IN PREDICTING MORTALITY IN PATIENTS WITH COVID-19
por: Noghondar, Keyvan Amini, et al.
Publicado: (2022)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

CARDIAC MAGNETIC RESONANCE (CMR) FINDINGS IN PATIENTS WITH ACUTE MYOCARDITIS AFTER RECEIVING THE SECOND DOSE OF COVID19 MRNA VACCINE: A SYSTEMATIC REVIEW
por: Alatta, Lina, et al.
Publicado: (2022)

RISK PREDICTORS FOR MYOCARDIAL INJURY IN SEVERE COVID-19
por: Nascimento, Jorge H.P., et al.
Publicado: (2021)

INITIAL TROPONIN LEVEL AND ECHOCARDIOGRAPHIC FINDINGS IN SEVERE COVID-19
por: Kumar, Sant, et al.
Publicado: (2021)

STATIN USE MAY BE ASSOCIATED WITH DECREASED SEVERITY OF COVID-19
por: Shadid, Husam, et al.
Publicado: (2021)

STRESS-INDUCED CARDIOMYOPATHY IN A PANDEMIC YEAR
por: Cundiff, Michael, et al.
Publicado: (2021)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

VASCULAR ENDOTHELIAL GROWTH FACTOR IS ASSOCIATED WITH SEVERE COVID-19 DISEASE
por: Solorzano, Juan, et al.
Publicado: (2022)

ASSOCIATION OF LIPID LEVELS WITH COVID-19 INFECTION, DISEASE SEVERITY AND MORTALITY
por: Chidambaram, Vignesh, et al.
Publicado: (2022)

COVID-19 COMPLICATED BY RESPIRATORY FAILURE INCREASES INPATIENT STEMI MORTALITY: MACHINE LEARNING-AUGMENTED MODIFIED PROPENSITY SCORE ADJUSTED LONGITUDINAL COHORT STUDY
por: Ynalvez, Leslie Ammabel, et al.
Publicado: (2023)

PERFORMANCE OF CURRENT THROMBOEMBOLISM RISK ASSESSMENT TOOLS IN PATIENTS WITH SEVERE COVID-19
por: Rios, Luis H. Paz, et al.
Publicado: (2021)

SEVERITY OF COVID-19 FURTHER INCREASES THE ODDS OF NEW-ONSET ATRIAL FIBRILLATION AND FLUTTER
por: Shah, Paras P., et al.
Publicado: (2022)

MODERATE/SEVERE MITRAL REGURGITATION AND TRICUSPID REGURGITATION ASSOCIATED WITH INCREASED MORTALITY IN HOSPITALIZED PATIENTS WITH COVID-19
por: Hasnie, Usman, et al.
Publicado: (2021)

A HIGH VOLUME, SINGLE CENTER STUDY OF VENO-VENOUS ECMO FOR COVID-19 ASSOCIATED SEVERE ARDS
por: Adams, Joseph, et al.
Publicado: (2021)

OUTCOMES OF PATIENTS WITH PULMONARY EMBOLISM WITH HISTORY OF COVID-19 ARE AS POOR AS PATIENTS WITH PULMONARY EMBOLISM WITH SEVERE COVID-19
por: Ho, Timothy D., et al.
Publicado: (2022)

CLINICAL PRESENTATION, DEMOGRAPHICS AND IN-HOSPITAL OUTCOME IN PATIENTS ADMITTED WITH MODERATE TO SEVERE COVID-19: MIDDLE EASTERN MULTICENTER DATA
por: Alkindi, Fahad, et al.
Publicado: (2021)

QT INTERVAL PROLONGATION IS A NOVEL PREDICTOR OF 1-YEAR MORTALITY IN PATIENTS WITH COVID-19 INFECTION
por: Banai, Ariel, et al.
Publicado: (2022)

AI ENHANCED ECG ENABLED RAPID NON-INVASIVE EXCLUSION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) INFECTION
por: Attia, Zachi Itzhak, et al.
Publicado: (2021)

SIGNIFICANT ETHNIC DIFFERENCES IN PREVALENCE, CARDIAC MANIFESTATIONS AND MORTALITY IN PATIENTS WITH MODERATE TO SEVERE COVID-19 BETWEEN MIDDLE EASTERN ARABS AND SOUTH ASIAN ETHNICITY
por: Alkindi, Fahad, et al.
Publicado: (2021)

ACE-I AND ARBS DO NOT INFLUENCE THE CHEST CT PRESENTATION AND 1-YEAR SURVIVAL OF COVID-19 PATIENTS: ITALIAN MULTICENTER REGISTRY
por: Birtolo, Lucia Ilaria, et al.
Publicado: (2022)

EVALUATION OF MICROVASCULAR FUNCTION AND SYSTEMIC INFLAMMATION IN THE ACUTE PHASE OF COVID-19 AND 1 YEAR AFTER RECOVERY: INSIGHTS INTO THE PATHOPHYSIOLOGY OF POST-COVID-19 SYNDROME
por: De Lorenzo, Andrea, et al.
Publicado: (2022)

H2C2 (HOME HOSPITAL AND CRITICAL CARE) - A 2.5 YEAR EXPERIENCE USING A NEW MODEL OF HOSPITAL AT HOME: DEVELOPMENT AND IMPLEMENTATION
por: Shen, Michael Y., et al.
Publicado: (2022)

THE IMPACT OF ORAL ANTICOAGULANTS ON THE OUTCOMES OF COVID-19 PATIENTS WITH A HISTORY OF HF AND ATRIAL FIBRILLATION
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022)

ONSET OF THE COVID-19 PANDEMIC REDUCED ACTIVE TIME IN PATIENTS WITH IMPLANTED PACEMAKERS
por: Sommers, Nicholas, et al.
Publicado: (2021)

ELECTROCARDIOGRAPHIC FINDINGS AMONG ALL-COMERS DIAGNOSED WITH COVID-19
por: Kassis, Nicholas, et al.
Publicado: (2022)

UTILITY OF AN AUTOMATED ARTIFICIAL INTELLIGENCE ECHOCARDIOGRAPHY SOFTWARE IN RISK STRATIFICATION OF HOSPITALIZED COVID-19 PATIENTS
por: Wang, Tom Kai Ming, et al.
Publicado: (2021)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

LIPID PANELS AND A1C LABS DURING THE COVID SURGE IN AN URBAN PRIMARY CARE RESIDENTS CLINIC
por: Shi, Hanyuan, et al.
Publicado: (2021)

LONGITUDINAL OUTPATIENT FOLLOW-UP OF CARDIAC BIOMARKERS AND ECHOCARDIOGRAPHIC FINDINGS IN CHILDREN AND ADOLESCENTS WITH MULTI INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) ASSOCIATED WITH COVID-19
por: Chakraborty, Abhishek, et al.
Publicado: (2022)

ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY
por: Nguyen, Nicholas, et al.
Publicado: (2021)

SUSTAINED IMPACT OF THE COVID-19 PANDEMIC ON PRESENTATIONS WITH ST-SEGMENTELEVATION MYOCARDIAL INFARCTION
por: Kassis, Nicholas, et al.
Publicado: (2022)

APABETALONE (RVX-208) REDUCES ACE2 PROTEIN ABUNDANCE AND PREVENTS SARS-COV-2 SPIKE PROTEIN BINDING TO HUMAN LUNG CELLS, A MOA THAT COULD ATTENUATE VIRAL ENTRY
por: Fu, Li, et al.
Publicado: (2021)

THE IMPACT OF COVID-19 ON PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME
por: Zaher, Nathan, et al.
Publicado: (2021)

CATHETER-DIRECTED THROMBOLYSIS IN COVID-19
por: Ammar, Ali, et al.
Publicado: (2022)

CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

OUTPATIENT CARDIAC MONITORING TO DETERMINE ARRHYTHMIC BURDEN AFTER COVID-19 HOSPITALIZATION
por: Beccarino, Nicholas, et al.
Publicado: (2022)

CARDIAC INVOLVEMENT IN COVID-19: INSIGHTS FROM A SAFETY NET URBAN HOSPITAL
por: Garcia, Mariana, et al.
Publicado: (2021)

META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
por: Sattar, Yasar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q67qf8m8i3apj7q5kk9i00ad31